Clinical Trials

34 enrolled

DermatologicLymphoid

Recurrence, Lymphoma, T-Cell, Cutaneous

NCT06367114 2024-04-19

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

LymphoidOther hematologic neoplasm

50 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04739670 2024-03-01

BELLA

31 enrolled

Breast

Recurrence, Triple Negative Breast Neoplasms

NCT05757466 2023-12-19

Prolgo-HL

Hodgkin Disease, Recurrence

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

82 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06103617 2023-11-18

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

10 enrolled

Head and Neck Neoplasms, Recurrence

NCT02624128 2023-11-13

V-CHANCE

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06074107 2023-10-11

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

128 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05626829 2023-10-06

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

18 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT03505554 2023-08-07

CRU3

12 enrolled

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT05951855 2023-07-19

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

42 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05940051 2023-07-11

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

35 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04671459 2023-06-28

TaRRGET

CNS

Glioblastoma, Recurrence

NCT05576532 2023-06-28

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05816746 2023-05-09

Decitabine and Anti-PD-1 in R/R DLBCL

20 enrolled

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01593488 2023-03-24

CILI

CNSLymphoidOther hematologic neoplasm

31 enrolled

Central Nervous System Diseases, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Recurrence, Leukemia, Myeloid, Acute

NCT04809181 2023-02-21

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

95 enrolled

Recurrence, Hematologic Neoplasms

NCT04113226 2023-02-08

Relyage

114 enrolled

LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT04913922 2022-11-08

AARON

Recurrence, Leukemia, Myeloid, Acute

NCT04015739 2022-08-17

BOLD

74 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Recurrence

NCT05495100 2022-08-10

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

45 enrolled

Recurrence, Lymphoma, T-Cell, Peripheral

NCT05320081 2022-04-11

Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma

Lymphoma, Recurrence

NCT04981665 2022-01-05

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05137886 2021-12-17

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

47 enrolled

Hodgkin Disease, Recurrence

NCT04948788 2021-09-28

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

102 enrolled

Recurrence, Lymphoma, B-Cell

NCT03467178 2021-09-05

MITO29

119 enrolled

Recurrence

NCT04994626 2021-08-06

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies

20 enrolled

Lymphoma, Recurrence

NCT04539444 2021-08-02

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

10 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT03245905 2021-03-16

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

100 enrolled

Recurrence, Lymphoma, B-Cell

NCT02636231 2021-02-03

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

96 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT04623333 2020-11-10

A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

80 enrolled

Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT03474133 2020-07-21

BASALT

80 enrolled

Hodgkin Disease, Recurrence

NCT04329130 2020-04-24

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

44 enrolled

Recurrence, Lymphoma, T-Cell, Peripheral

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

20 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03297528 2020-03-10

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Graft vs Host Disease, Recurrence, Neoplasm, Residual

NCT03613753 2020-02-05

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

72 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT03913182 2020-02-05

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

39 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence

NCT02267915 2020-01-27

MAN2

36 enrolled

Recurrence, Lymphoma, Mantle-Cell

NCT04126460 2019-10-15

RePASS

41 enrolled

Head and Neck Neoplasms, Recurrence

NCT02060656 2019-09-19

LEGEND

92 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02747732 2019-04-23

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

72 enrolled

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03196830 2019-04-16

CAR-T for R/R B-NHL

10 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT03250962 2019-04-01

SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

280 enrolled

Hodgkin Disease, Recurrence

NCT02007148 2019-02-27

MICADO

51 enrolled

Neoplasm Metastasis, Recurrence

NCT03770988 2019-02-22

A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

49 enrolled

Recurrence

NCT03776279 2018-12-14

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

106 enrolled

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT03771222 2018-12-13

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Graft vs Host Disease, Recurrence

NCT03601624 2018-11-14

MM-POM-2018